This study collected samples from NSCLC patients with TP53/EGFR co-mutations and provided a comprehensive landscape of the TME and its adjacent normal tissues at single-cell resolution through scRNA-seq analysis. The gene discussed is TP53; the disease is non-small cell lung carcinoma.